Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) View the PDF document
Table of Contents
View the documentAuthors
View the documentCountry Research Team Leaders
View the documentLaboratory Support
View the documentAcknowledgements
View the documentAcronyms
View the documentExecutive summary
View the document1. Background
Open this folder and view contents2. Methodology
View the document3. Results
Open this folder and view contents4. Discussion
Open this folder and view contents5. Conclusions and recommendations
View the documentReferences
Open this folder and view contentsTables
Open this folder and view contentsAnnexes
View the documentOther documents in the EDM Research Series
View the documentEDM Research Series No. 30
 

References

1. Matteelli A. et al. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine/pyrimethamine, Zanzibar, United Republic of Tanzania. Geneva, World Health Organization, 1990. (WHO/MAL/90.1055).

2. Walker GJA, Hogerzeil HV. Potency of ergometrine in tropical countries. Letter to the Editor. Lancet, 1988, ii: 393.

3. Hogerzeil HV, Walker GJA. Instability of (methyl) ergometrine in tropical climates: an overview. European Journal of Obstetrics Gynecology and Reproductive Biology, 1996, 69: 25-29.

4. Hogerzeil HV et al. Stability of essential drugs during shipment to the tropics. Letter to the Editor. British Medical Journal, 1992, 304: 210-212.

5. Nazerali H, Hogerzeil HV. The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study. British Medical Journal, 1998, 317: 512-513.

6. Wondemagegnehu E. Counterfeit and substandard drugs in Myanmar and Viet Nam. Geneva, World Health Organization; 1999. (WHO/EDM/QSM/99.3).

7. World Health Organization. Guidelines for the development of measures to combat counterfeit drugs, DMP-DAP Joint Project on Counterfeit Drugs. Geneva, World Health Organization, 1999. (WHO/EDM/QSM/99.1).

8. World Health Organization. Monitoring antimalarial drug resistance. Geneva, World Health Organization, 2002. (WHO/CDS/CSR/EPH/2002.17 and WHO/CDS/RBM/2002.39).

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018